Genetic Polymorphisms in IL1R1 and IL1R2 Are Associated with Susceptibility to Thyroid Cancer in the Chinese Han Population.

Zichao Xiong,Yao Sun,Jiamin Wu,Fanglin Niu,Tianbo Jin,Bin Li
DOI: https://doi.org/10.1002/jgm.3093
2019-01-01
Abstract:Background Thyroid carcinoma accounts for a large part of endocrine neoplasia and the relationship between inflammation and thyroid cancer has been validated previously. Two known receptors of interleukin (IL)-1, IL-1 receptor 1 (IL1R1) and IL-1 receptor 2 (IL1R2), are implicated in numerous inflammatory responses. The present study aimed to assess the genetic polymorphisms of IL1R1 and IL1R2 with respect to thyroid cancer in the Chinese Han population. Methods Eleven single nucleotide polymorphisms of IL1R1 and IL1R2 were identified among 241 thyroid cancer patients and 463 controls using the Agena MassARRY method (). Genetic models and haplotype analysis were carried out to evaluate the significant links between the variants and the risk of thyroid cancer. Results Logistic regression analyses revealed significant associations of rs3917225, rs2072472 and rs11674595 with susceptibility to thyroid cancer. Haplotype analysis presented two blocks of IL1R2, whereas no statistical significance existed. Conclusions These findings suggested that rs3917225, rs2072472 and rs11674595 are risk factors associated with the development of thyroid carcinoma in Chinese Han people.
What problem does this paper attempt to address?